Summy Amy B.
SEC CIK 1805303 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LH | Labcorp | EVP, CMO | 6,956 | — | $2.27M | 42 | 2022-02-02 | 2026-08-04 |
Most active insiders at LH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schechter Adam H | Pres, CEO, Dir | — | $8.44M |
| 2 | Parham Richelle P | Dir | — | $1.78M |
| 3 | Wilkinson Peter J | SVP, CAO | — | $1.06M |
| 4 | ANDERSON KERRII B | Dir | — | $954.1K |
| 5 | Caveney Brian J | EVP, CMO, CSO, Pres of ED | — | $429.5K |
| 6 | Meltzer Jonathan C | EVP, Ops | — | $298.8K |
| 7 | Summy Amy B. | EVP, CMO | — | $283.4K |
| 8 | Kyle Kathryn W | EVP, CLO | — | $227.4K |
| 9 | van der Vaart Sandra D | EVP, Corp. Affairs | — | $156.0K |
| 10 | Vaughn Bryan T | EVP, Pres, Diagnostics | — | $67.0K |
Transactions 42
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 08:26 | 2026-08-04 | LH | Labcorp | Summy Amy B. | EVP, CMO | S - Sale | $306.74 | -924 | 6,956 | -12% | -$283.4K | |
| 2026-03-30 | 2026-03-26 | LH | Labcorp | Summy Amy B. | EVP, CMO | A - Grant | $0.00 | +3,994 | 9,716 | +70% | $0 | |
| 2026-03-30 | 2026-03-26 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $268.38 | -1,836 | 7,880 | -19% | -$492.7K | |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $289.89 | -83 | 5,722 | -1% | -$24.1K |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +230 | 5,804 | +4% | — |
| DM | 2026-02-10 | 2026-02-06+ | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $275.72 | -172 | 5,432 | -3% | -$47.4K |
| DM | 2026-02-10 | 2026-02-06+ | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +445 | 5,654 | +9% | — |
| 2025-03-31 | 2025-03-27 | LH | Labcorp | Summy Amy B. | EVP, CMO | A - Grant | $0.00 | +2,077 | 6,622 | +46% | $0 | |
| 2025-03-31 | 2025-03-27 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $231.67 | -562 | 6,060 | -8% | -$130.2K | |
| 2025-03-31 | 2025-03-28 | LH | Labcorp | Summy Amy B. | EVP, CMO | S - Sale | $231.67 | -758 | 5,302 | -13% | -$175.6K | |
| 2025-02-26 | 2025-02-24 | LH | Labcorp | Summy Amy B. | EVP, CMO | S - Sale | $250.40 | -226 | 4,544 | -5% | -$56.6K | |
| D | 2025-02-13 | 2025-02-11 | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +201 | 4,826 | +4% | — |
| D | 2025-02-13 | 2025-02-11 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $245.14 | -55 | 4,770 | -1% | -$13.5K |
| DM | 2025-02-10 | 2025-02-06+ | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +447 | 4,542 | +11% | — |
| DM | 2025-02-10 | 2025-02-06+ | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $247.03 | -141 | 4,468 | -3% | -$34.8K |
| D | 2024-11-26 | 2024-11-22 | LH | Labcorp | Summy Amy B. | EVP, CMO | S - Sale+OE | $238.91 | -3,672 | 4,318 | -46% | -$877.2K |
| D | 2024-11-26 | 2024-11-22 | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | $168.52 | +4,015 | 7,990 | +101% | +$676.6K |
| 2024-04-03 | 2024-04-01 | LH | Labcorp | Summy Amy B. | EVP, CMO | S - Sale | $217.29 | -3,500 | 3,975 | -47% | -$760.5K | |
| D | 2024-03-29 | 2024-03-27 | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +5,778 | 9,637 | +150% | — |
| D | 2024-03-29 | 2024-03-27 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $216.57 | -2,162 | 7,475 | -22% | -$468.2K |
| 2024-03-11 | 2024-03-07 | LH | Labcorp | Summy Amy B. | EVP, CMO | S - Sale | $218.45 | -227 | 3,859 | -6% | -$49.6K | |
| D | 2024-02-13 | 2024-02-12 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $227.45 | -66 | 4,086 | -2% | -$15.0K |
| D | 2024-02-13 | 2024-02-11 | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +201 | 4,152 | +5% | — |
| D | 2024-02-08 | 2024-02-07 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $223.71 | -73 | 3,951 | -2% | -$16.3K |
| D | 2024-02-08 | 2024-02-07 | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +224 | 4,024 | +6% | — |
| D | 2024-02-06 | 2024-02-02 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $221.54 | -80 | 3,800 | -2% | -$17.7K |
| D | 2024-02-06 | 2024-02-02 | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +246 | 3,880 | +7% | — |
| 2023-04-03 | 2023-03-30 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $224.70 | -1,269 | 3,634 | -26% | -$285.1K | |
| 2023-04-03 | 2023-03-30 | LH | Labcorp | Summy Amy B. | EVP, CMO | A - Grant | $0.00 | +3,234 | 4,903 | +194% | $0 | |
| D | 2023-03-06 | 2023-03-02 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $239.46 | -374 | 1,669 | -18% | -$89.6K |
| D | 2023-03-06 | 2023-03-02 | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +1,340 | 2,043 | +191% | — |
| D | 2023-02-14 | 2023-02-11 | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +180 | 757 | +31% | — |
| D | 2023-02-14 | 2023-02-13 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $248.13 | -54 | 703 | -7% | -$13.4K |
| D | 2023-02-07 | 2023-02-06 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $244.50 | -83 | 577 | -13% | -$20.3K |
| D | 2023-02-07 | 2023-02-04 | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +267 | 660 | +68% | — |
| D | 2023-02-06 | 2023-02-02 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $254.99 | -77 | 393 | -16% | -$19.6K |
| D | 2023-02-06 | 2023-02-02 | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +220 | 470 | +88% | — |
| 2022-03-14 | 2022-03-10 | LH | Labcorp | Summy Amy B. | EVP, CMO | S - Sale | $262.21 | -249 | 250 | -50% | -$65.3K | |
| D | 2022-02-08 | 2022-02-04 | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +267 | 582 | +85% | — |
| D | 2022-02-08 | 2022-02-04 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $277.48 | -83 | 499 | -14% | -$23.0K |
| D | 2022-02-04 | 2022-02-02 | LH | Labcorp | Summy Amy B. | EVP, CMO | F - Tax | $273.18 | -77 | 315 | -20% | -$21.0K |
| D | 2022-02-04 | 2022-02-02 | LH | Labcorp | Summy Amy B. | EVP, CMO | M - OptEx | — | +220 | 392 | +128% | — |
Purchase Sale Sale after option exercise All abbreviations